Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system

Giancarlo Icardi, Andrea Orsi, Antonella Ceravolo, Filippo Ansaldi

Research output: Contribution to journalArticlepeer-review

Abstract

Among the several strategies explored for (1) the enhancement of the immune response to influenza immunization, (2) the improvement of the vaccine acceptability and (3) the overcoming of the egg-dependency for vaccine production, intradermal administration of influenza vaccine emerges as a promising alternative to conventional intramuscular route, thanks to the recent availability of new delivery devices and the perception of advantages in terms of immunogenicity, safety, reduction of antigen content and acceptability. Data from clinical trials performed in children, adults

Original languageEnglish
Pages (from-to)69-77
Number of pages9
JournalHuman Vaccines and Immunotherapeutics
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 2012

Keywords

  • Acceptability
  • Immunogenicity
  • Influenza vaccine
  • Intradermal
  • Micro injection system
  • Safety
  • Tolerability

ASJC Scopus subject areas

  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system'. Together they form a unique fingerprint.

Cite this